{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:57:32Z","timestamp":1793372252360,"version":"4.5.0"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"am","delay-in-days":355,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 CA217798"],"award-info":[{"award-number":["P01 CA217798"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA218545"],"award-info":[{"award-number":["R01 CA218545"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA241752"],"award-info":[{"award-number":["R01 CA241752"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01"],"award-info":[{"award-number":["U01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 CA185148"],"award-info":[{"award-number":["U01 CA185148"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 CA200466"],"award-info":[{"award-number":["U01 CA200466"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-18"],"award-info":[{"award-number":["W81XWH-18"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013134","name":"US Department of Defense Military Health System","doi-asserted-by":"publisher","award":["W81XWH-18\u20131\u20130308"],"award-info":[{"award-number":["W81XWH-18\u20131\u20130308"]}],"id":[{"id":"10.13039\/100013134","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013134","name":"US Department of Defense Military Health System","doi-asserted-by":"publisher","award":["W81XWH-21\u20131\u20130640"],"award-info":[{"award-number":["W81XWH-21\u20131\u20130640"]}],"id":[{"id":"10.13039\/100013134","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004354","name":"Svensk K\u00e4rnbr\u00e4nslehantering","doi-asserted-by":"publisher","award":["R01 CA195586"],"award-info":[{"award-number":["R01 CA195586"]}],"id":[{"id":"10.13039\/501100004354","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004354","name":"Svensk K\u00e4rnbr\u00e4nslehantering","doi-asserted-by":"publisher","award":["U01 CA213862"],"award-info":[{"award-number":["U01 CA213862"]}],"id":[{"id":"10.13039\/501100004354","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.cytogfr.2021.11.002","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T03:45:11Z","timestamp":1637120711000},"page":"71-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":185,"special_numbering":"C","title":["Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia"],"prefix":"10.1016","volume":"64","author":[{"given":"Jawed Akhtar","family":"Siddiqui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Pothuraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvez","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunjan","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakthivel","family":"Muniyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parthasarathy","family":"Seshacharyulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maneesh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Wasim","family":"Nasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder Kumar","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cytogfr.2021.11.002_bib1","first-page":"649","article-title":"NSAID activated gene (NAG-1), a modulator of tumorigenesis","volume":"39","author":"Eling","year":"2006","journal-title":"J. Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.11.002_bib2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1373\/clinchem.2006.076828","article-title":"Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay","volume":"53","author":"Kempf","year":"2007","journal-title":"Clin. Chem."},{"issue":"7","key":"10.1016\/j.cytogfr.2021.11.002_bib3","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1158\/1078-0432.CCR-03-0165","article-title":"Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers","volume":"10","author":"Koopmann","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"21","key":"10.1016\/j.cytogfr.2021.11.002_bib4","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1158\/1078-0432.CCR-08-3126","article-title":"Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer","volume":"15","author":"Brown","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.11.002_bib5","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/jcp.22196","article-title":"Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer","volume":"224","author":"Mimeault","year":"2010","journal-title":"J. Cell Physiol."},{"issue":"14","key":"10.1016\/j.cytogfr.2021.11.002_bib6","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1158\/1078-0432.CCR-11-0715","article-title":"Elevated plasma growth differentiation factor-15 correlates with lymph node metastases and poor survival in endometrial cancer","volume":"17","author":"Staff","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cytogfr.2021.11.002_bib7","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1186\/1471-2407-14-578","article-title":"Macrophage inhibitory cytokine 1 (MIC-1\/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma","volume":"14","author":"Wang","year":"2014","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.cytogfr.2021.11.002_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jlb.65.1.2","article-title":"MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation","volume":"65","author":"Fairlie","year":"1999","journal-title":"J. Leukoc. Biol."},{"issue":"10","key":"10.1016\/j.cytogfr.2021.11.002_bib9","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/nm.4393","article-title":"The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL","volume":"23","author":"Emmerson","year":"2017","journal-title":"Nat. Med."},{"issue":"7675","key":"10.1016\/j.cytogfr.2021.11.002_bib10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature24042","article-title":"Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15","volume":"550","author":"Hsu","year":"2017","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.cytogfr.2021.11.002_bib11","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/nm.4392","article-title":"GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates","volume":"23","author":"Mullican","year":"2017","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.11.002_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100370","article-title":"The anorectic actions of the TGFbeta cytokine MIC-1\/GDF15 require an intact brainstem area postrema and nucleus of the solitary tract","volume":"9","author":"Tsai","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.cytogfr.2021.11.002_bib13","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/nm.4394","article-title":"GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand","volume":"23","author":"Yang","year":"2017","journal-title":"Nat. Med."},{"issue":"7011","key":"10.1016\/j.cytogfr.2021.11.002_bib14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature03001","article-title":"Finishing the euchromatic sequence of the human genome","volume":"431","author":"C. International Human Genome Sequencing","year":"2004","journal-title":"Nature"},{"issue":"6982","key":"10.1016\/j.cytogfr.2021.11.002_bib15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature02399","article-title":"The DNA sequence and biology of human chromosome 19","volume":"428","author":"Grimwood","year":"2004","journal-title":"Nature"},{"issue":"6822","key":"10.1016\/j.cytogfr.2021.11.002_bib16","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35057062","article-title":"C. International human genome sequencing, initial sequencing and analysis of the human genome","volume":"409","author":"Lander","year":"2001","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.cytogfr.2021.11.002_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00249-18","article-title":"Growth differentiation factor 15 maturation requires proteolytic cleavage by PCSK3, -5, and -6","volume":"38","author":"Li","year":"2018","journal-title":"Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.cytogfr.2021.11.002_bib18","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00424-020-02459-1","article-title":"GDF15, an update of the physiological and pathological roles it plays: a review","volume":"472","author":"Assadi","year":"2020","journal-title":"Pflugers Arch"},{"issue":"7675","key":"10.1016\/j.cytogfr.2021.11.002_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature24042","article-title":"Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15","volume":"550","author":"Hsu","year":"2017","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.cytogfr.2021.11.002_bib20","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s41591-020-0945-x","article-title":"Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice","volume":"26","author":"Suriben","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.cytogfr.2021.11.002_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101117","article-title":"Growth differentiation factor 15 as a potential therapeutic for treating obesity","volume":"46","author":"Hale","year":"2021","journal-title":"Mol. Metab."},{"issue":"8","key":"10.1016\/j.cytogfr.2021.11.002_bib22","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.soard.2016.04.017","article-title":"Prevalence, severity, and predictors of symptoms of dumping and hypoglycemia after Roux-en-Y gastric bypass","volume":"12","author":"Nielsen","year":"2016","journal-title":"Surg. Obes. Relat. Dis."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.11.002_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055174","article-title":"TGF-b superfamily cytokine MIC-1\/GDF15 is a physiological appetite and body weight regulator","volume":"8","author":"Tsai","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cytogfr.2021.11.002_bib24","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1053\/j.gastro.2006.09.015","article-title":"Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia","volume":"131","author":"Baek","year":"2006","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cytogfr.2021.11.002_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034868","article-title":"Macrophage inhibitory cytokine 1 (MIC-1\/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets","volume":"7","author":"Macia","year":"2012","journal-title":"PLoS One"},{"issue":"412","key":"10.1016\/j.cytogfr.2021.11.002_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan8732","article-title":"Long-acting MIC-1\/GDF15 molecules to treat obesity: evidence from mice to monkeys","volume":"9","author":"Xiong","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.11.002_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4161\/oxim.3.6.14415","article-title":"Signaling of reactive oxygen and nitrogen species in Diabetes mellitus","volume":"3","author":"Afanas\u2019ev","year":"2010","journal-title":"Oxid. Med. Cell Longev."},{"issue":"12","key":"10.1016\/j.cytogfr.2021.11.002_bib28","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/ijo.2014.27","article-title":"NAG-1\/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism","volume":"38","author":"Chrysovergis","year":"2014","journal-title":"Int. J. Obes."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.11.002_bib29","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cellsig.2005.05.009","article-title":"High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K\/Akt\/eNOS pathway","volume":"18","author":"Ho","year":"2006","journal-title":"Cell Signal"},{"issue":"6","key":"10.1016\/j.cytogfr.2021.11.002_bib30","article-title":"Adaptive induction of growth differentiation factor 15 attenuates endothelial cell apoptosis in response to high glucose stimulus","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cytogfr.2021.11.002_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.canlet.2008.11.013","article-title":"p53 controls prostate-derived factor\/macrophage inhibitory cytokine\/NSAID-activated gene expression in response to cell density, DNA damage and hypoxia through diverse mechanisms","volume":"277","author":"Kelly","year":"2009","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.cytogfr.2021.11.002_bib32","doi-asserted-by":"crossref","first-page":"F1249","DOI":"10.1152\/ajprenal.00387.2013","article-title":"Genetic deletion of growth differentiation factor 15 augments renal damage in both type 1 and type 2 models of diabetes","volume":"305","author":"Mazagova","year":"2013","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.11.002_bib33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1530\/EJE-09-0417","article-title":"Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet","volume":"161","author":"Dostalova","year":"2009","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.11.002_bib34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/HYPERTENSIONAHA.109.130583","article-title":"Circulating and placental growth-differentiation factor 15 in preeclampsia and in pregnancy complicated by diabetes mellitus","volume":"54","author":"Sugulle","year":"2009","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.cytogfr.2021.11.002_bib35","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1530\/EJE-09-1066","article-title":"Macrophage inhibitory cytokine-1 is increased in individuals before type 2 diabetes diagnosis but is not an independent predictor of type 2 diabetes: the Whitehall II study","volume":"162","author":"Carstensen","year":"2010","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.11.002_bib36","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cmet.2018.12.016","article-title":"GDF15 provides an endocrine signal of nutritional stress in mice and humans","volume":"29","author":"Patel","year":"2019","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.11.002_bib37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/ijo.2015.242","article-title":"Anorexia-cachexia and obesity treatment may be two sides of the same coin: role of the TGF-b superfamily cytokine MIC-1\/GDF15","volume":"40","author":"Tsai","year":"2016","journal-title":"Int. J. Obes."},{"issue":"21","key":"10.1016\/j.cytogfr.2021.11.002_bib38","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","article-title":"MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily","volume":"94","author":"Bootcov","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"1","key":"10.1016\/j.cytogfr.2021.11.002_bib39","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-2265.2011.04139.x","article-title":"Hyperinsulinemia acutely increases serum macrophage inhibitory cytokine-1 concentration in anorexia nervosa and obesity","volume":"76","author":"Karczewska-Kupczewska","year":"2012","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.11.002_bib40","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1530\/EJE-16-0550","article-title":"Growth differentiation factor 15 increases following oral glucose ingestion: effect of meal composition and obesity","volume":"175","author":"Schernthaner-Reiter","year":"2016","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.cytogfr.2021.11.002_bib41","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.numecd.2018.12.008","article-title":"GDF15 reflects beta cell function in obese patients independently of the grade of impairment of glucose metabolism","volume":"29","author":"Schernthaner-Reiter","year":"2019","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.cytogfr.2021.11.002_bib42","article-title":"Growth differentiation factor-15 as a biomarker of obese pre-diabetes and type 2 diabetes mellitus in indian subjects: a case-control study","author":"Roy","year":"2021","journal-title":"Curr. Diabetes Rev."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.11.002_bib43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12933-020-01020-9","article-title":"The association between serum growth differentiation factor 15 levels and lower extremity atherosclerotic disease is independent of body mass index in type 2 diabetes","volume":"19","author":"He","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.11.002_bib44","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Prevention program research, reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.11.002_bib45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00125-005-0097-z","article-title":"P. Indian diabetes prevention, the indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in asian indian subjects with impaired glucose tolerance (IDPP-1)","volume":"49","author":"Ramachandran","year":"2006","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.cytogfr.2021.11.002_bib46","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2337\/db06-0918","article-title":"Factors associated with diabetes onset during metformin versus placebo therapy in the diabetes prevention program","volume":"56","author":"Lachin","year":"2007","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.cytogfr.2021.11.002_bib47","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.cytogfr.2021.11.002_bib48","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2337\/dc16-1682","article-title":"O. Investigators, growth differentiation Factor 15 as a novel biomarker for metformin","volume":"40","author":"Gerstein","year":"2017","journal-title":"Diabetes Care"},{"issue":"7795","key":"10.1016\/j.cytogfr.2021.11.002_bib49","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-019-1911-y","article-title":"GDF15 mediates the effects of metformin on body weight and energy balance","volume":"578","author":"Coll","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2021.11.002_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.581839","article-title":"GDF-15 as a weight watcher for diabetic and non-diabetic people treated with metformin","volume":"11","author":"Ouyang","year":"2020","journal-title":"Front. Endocrinol."},{"issue":"10","key":"10.1016\/j.cytogfr.2021.11.002_bib51","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1158\/0008-5472.CAN-05-4067","article-title":"Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer","volume":"66","author":"Bauskin","year":"2006","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.cytogfr.2021.11.002_bib52","doi-asserted-by":"crossref","first-page":"946","DOI":"10.5966\/sctm.2013-0055","article-title":"Concise review: growth differentiation factor 15 in pathology: a clinical role?","volume":"2","author":"Corre","year":"2013","journal-title":"Stem Cells Transl. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.11.002_bib53","doi-asserted-by":"crossref","first-page":"860","DOI":"10.18632\/oncotarget.6205","article-title":"GDF15 promotes EMT and metastasis in colorectal cancer","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.cytogfr.2021.11.002_bib54","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cytogfr.2013.05.003","article-title":"The multiple facets of the TGF-beta family cytokine growth\/differentiation factor-15\/macrophage inhibitory cytokine-1","volume":"24","author":"Unsicker","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"issue":"9","key":"10.1016\/j.cytogfr.2021.11.002_bib55","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.bcp.2011.07.082","article-title":"Growth differentiation factor 15 (GDF15)-mediated HER2 phosphorylation reduces trastuzumab sensitivity of HER2-overexpressing breast cancer cells","volume":"82","author":"Joshi","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.11.002_bib56","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1073\/pnas.0530278100","article-title":"Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum","volume":"100","author":"Welsh","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"1","key":"10.1016\/j.cytogfr.2021.11.002_bib57","first-page":"218","article-title":"The expression of growth differentiation factor 15 in gallbladder carcinoma","volume":"26","author":"Yan","year":"2021","journal-title":"J. BUON"},{"issue":"1","key":"10.1016\/j.cytogfr.2021.11.002_bib58","doi-asserted-by":"crossref","first-page":"16824","DOI":"10.1038\/s41598-017-17207-2","article-title":"Relevance of MIC-1 in the era of PSA as a serum based predictor of prostate cancer: a critical evaluation","volume":"7","author":"Bansal","year":"2017","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.cytogfr.2021.11.002_bib59","doi-asserted-by":"crossref","first-page":"7696","DOI":"10.1158\/0008-5472.CAN-08-4901","article-title":"Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profiling","volume":"69","author":"Zhao","year":"2009","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.cytogfr.2021.11.002_bib60","article-title":"Macrophage inhibitory cytokine 1 biomarker serum immunoassay in combination with PSA is a more specific diagnostic tool for detection of prostate cancer","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.cytogfr.2021.11.002_bib61","doi-asserted-by":"crossref","first-page":"13760","DOI":"10.1074\/jbc.273.22.13760","article-title":"Cloning and characterization of a novel member of the transforming growth factor-beta\/bone morphogenetic protein family","volume":"273","author":"Paralkar","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.11.002_bib62","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0006-291X(03)00823-4","article-title":"Dysregulated expression of MIC-1\/PDF in human prostate tumor cells","volume":"305","author":"Karan","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.cytogfr.2021.11.002_bib63","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/onc.2009.420","article-title":"Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway","volume":"29","author":"Senapati","year":"2010","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.cytogfr.2021.11.002_bib64","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/pros.20551","article-title":"Prostate-derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor-positive human prostate cancer cells","volume":"67","author":"Chen","year":"2007","journal-title":"Prostate"},{"issue":"8","key":"10.1016\/j.cytogfr.2021.11.002_bib65","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1210\/en.2011-0059","article-title":"Wild-type p53 attenuates cancer cell motility by inducing growth differentiation factor-15 expression","volume":"152","author":"Cheng","year":"2011","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.cytogfr.2021.11.002_bib66","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/bjc.2012.484","article-title":"Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1","volume":"108","author":"Mimeault","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"16","key":"10.1016\/j.cytogfr.2021.11.002_bib67","first-page":"5034","article-title":"Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells","volume":"63","author":"Liu","year":"2003","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.11.002_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233846","article-title":"Growth differentiation factor-15 slows the growth of murine prostate cancer by stimulating tumor immunity","volume":"15","author":"Husaini","year":"2020","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.cytogfr.2021.11.002_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043833","article-title":"Macrophage inhibitory cytokine-1 (MIC-1\/GDF15) slows cancer development but increases metastases in TRAMP prostate cancer prone mice","volume":"7","author":"Husaini","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cytogfr.2021.11.002_bib70","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.bcp.2012.11.025","article-title":"The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1\/GDF15) in cancer","volume":"85","author":"Wang","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cytogfr.2021.11.002_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.3850","article-title":"Growth and differentiation factor 15 and NF-kappaB expression in benign prostatic biopsies and risk of subsequent prostate cancer detection","author":"Rybicki","year":"2021","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.11.002_bib72","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0014-5793(00)01291-6","article-title":"Profile of gene expression regulated by induced p53: connection to the TGF-beta family","volume":"470","author":"Kannan","year":"2000","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.11.002_bib73","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1158\/1055-9965.EPI-06-0063","article-title":"Macrophage inhibitory cytokine-1 H6D polymorphism, prostate cancer risk, and survival","volume":"15","author":"Hayes","year":"2006","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"5","key":"10.1016\/j.cytogfr.2021.11.002_bib74","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/carcin\/bgi031","article-title":"The macrophage inhibitory cytokine integrates AKT\/PKB and MAP kinase signaling pathways in breast cancer cells","volume":"26","author":"Wollmann","year":"2005","journal-title":"Carcinogenesis"},{"issue":"13","key":"10.1016\/j.cytogfr.2021.11.002_bib75","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1158\/0008-5472.CAN-13-2259","article-title":"Local and systemic protumorigenic effects of cancer-associated fibroblast-derived GDF15","volume":"74","author":"Bruzzese","year":"2014","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.11.002_bib76","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1158\/1055-9965.EPI-06-0841","article-title":"Serum macrophage inhibitory cytokine-1 concentrations correlate with the presence of prostate cancer bone metastases","volume":"16","author":"Selander","year":"2007","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.11.002_bib77","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/pros.20913","article-title":"Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss","volume":"69","author":"Wakchoure","year":"2009","journal-title":"Prostate"},{"issue":"23","key":"10.1016\/j.cytogfr.2021.11.002_bib78","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1038\/s41388-019-0736-3","article-title":"Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion","volume":"38","author":"Wang","year":"2019","journal-title":"Oncogene"},{"issue":"55","key":"10.1016\/j.cytogfr.2021.11.002_bib79","doi-asserted-by":"crossref","first-page":"94393","DOI":"10.18632\/oncotarget.21765","article-title":"Growth differentiation factor 15 mediates epithelial mesenchymal transition and invasion of breast cancers through IGF-1R-FoxM1 signaling","volume":"8","author":"Peake","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.cytogfr.2021.11.002_bib80","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.21873\/anticanres.14079","article-title":"Silencing of Growth Differentiation Factor-15 Promotes Breast Cancer Cell Invasion by Down-regulating Focal Adhesion Genes","volume":"40","author":"Gkretsi","year":"2020","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.11.002_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20010163","article-title":"Inhibition of breast cancer cell invasion by ras suppressor-1 (RSU-1) silencing is reversed by growth differentiation factor-15 (GDF-15)","volume":"20","author":"Gkretsi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"43","key":"10.1016\/j.cytogfr.2021.11.002_bib82","doi-asserted-by":"crossref","first-page":"43ra56","DOI":"10.1126\/scitranslmed.3001127","article-title":"Ferroportin and iron regulation in breast cancer progression and prognosis","volume":"2","author":"Pinnix","year":"2010","journal-title":"Sci. Transl. Med."},{"issue":"29","key":"10.1016\/j.cytogfr.2021.11.002_bib83","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1038\/s41388-018-0243-y","article-title":"Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer","volume":"37","author":"Blanchette-Farra","year":"2018","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.cytogfr.2021.11.002_bib84","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/carcin\/bgn031","article-title":"Macrophage inhibitory cytokine-1 activates AKT and ERK-1\/2 via the transactivation of ErbB2 in human breast and gastric cancer cells","volume":"29","author":"Kim","year":"2008","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.cytogfr.2021.11.002_bib85","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2174\/0929867320666131119155023","article-title":"P38 MAPK contributes to resistance and invasiveness of HER2- overexpressing breast cancer","volume":"21","author":"Donnelly","year":"2014","journal-title":"Curr. Med. Chem."},{"issue":"15","key":"10.1016\/j.cytogfr.2021.11.002_bib86","doi-asserted-by":"crossref","first-page":"24869","DOI":"10.18632\/oncotarget.15276","article-title":"An autocrine\/paracrine circuit of growth differentiation factor (GDF) 15 has a role for maintenance of breast cancer stem-like cells","volume":"8","author":"Sasahara","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.cytogfr.2021.11.002_bib87","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cell.2005.06.007","article-title":"The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP","volume":"122","author":"Huang","year":"2005","journal-title":"Cell"},{"issue":"5 Pt A","key":"10.1016\/j.cytogfr.2021.11.002_bib88","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.bbadis.2018.02.020","article-title":"YAP promotes breast cancer metastasis by repressing growth differentiation factor-15","volume":"1864","author":"Wang","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.11.002_bib89","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.11.002_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055171","article-title":"Potentials of plasma NGAL and MIC-1 as biomarker(s) in the diagnosis of lethal pancreatic cancer","volume":"8","author":"Kaur","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.cytogfr.2021.11.002_bib91","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009994","article-title":"Macrophage inhibitory cytokine-1 versus carbohydrate antigen 19-9 as a biomarker for diagnosis of pancreatic cancer: A PRISMA-compliant meta-analysis of diagnostic accuracy studies","volume":"97","author":"Yang","year":"2018","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.cytogfr.2021.11.002_bib92","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3233\/CBM-170203","article-title":"Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass","volume":"21","author":"Hogendorf","year":"2018","journal-title":"Cancer Biomark"},{"issue":"14","key":"10.1016\/j.cytogfr.2021.11.002_bib93","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3748\/wjg.v26.i14.1660","article-title":"Macrophage inhibitory cytokine-1\/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort","volume":"26","author":"O\u2019Neill","year":"2020","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.cytogfr.2021.11.002_bib94","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1172\/JCI91561","article-title":"NF-kappaB regulates GDF-15 to suppress macrophage surveillance during early tumor development","volume":"127","author":"Ratnam","year":"2017","journal-title":"J. Clin. Invest"},{"issue":"3","key":"10.1016\/j.cytogfr.2021.11.002_bib95","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.3892\/mmr.2015.3867","article-title":"Twist promotes invasion and cisplatin resistance in pancreatic cancer cells through growth differentiation factor 15","volume":"12","author":"Ji","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.11.002_bib96","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41420-021-00462-8","article-title":"NR5A2 transcriptional activation by BRD4 promotes pancreatic cancer progression by upregulating GDF15","volume":"7","author":"Guo","year":"2021","journal-title":"Cell Death Discov"},{"issue":"1","key":"10.1016\/j.cytogfr.2021.11.002_bib97","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41598-018-37425-6","article-title":"Solid stress-induced migration is mediated by GDF15 through Akt pathway activation in pancreatic cancer cells","volume":"9","author":"Kalli","year":"2019","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.cytogfr.2021.11.002_bib98","first-page":"22564","article-title":"Upregulated GDF-15 expression facilitates pancreatic ductal adenocarcinoma progression through orphan receptor GFRAL","volume":"12","author":"Zhao","year":"2020","journal-title":"Aging"},{"issue":"61","key":"10.1016\/j.cytogfr.2021.11.002_bib99","doi-asserted-by":"crossref","first-page":"103557","DOI":"10.18632\/oncotarget.21581","article-title":"CXXC4 activates apoptosis through up-regulating GDF15 in gastric cancer","volume":"8","author":"Han","year":"2017","journal-title":"Oncotarget"},{"issue":"15","key":"10.1016\/j.cytogfr.2021.11.002_bib100","first-page":"4648","article-title":"Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system","volume":"63","author":"Lee","year":"2003","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.11.002_bib101","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3892\/ijo.2016.3556","article-title":"S100A4 influences cancer stem cell-like properties of MGC803 gastric cancer cells by regulating GDF15 expression","volume":"49","author":"Guo","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"15","key":"10.1016\/j.cytogfr.2021.11.002_bib102","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.7150\/jca.55511","article-title":"Expression of the body-weight signaling players: GDF15, GFRAL and RET and their clinical relevance in Gastric Cancer","volume":"12","author":"Buchholz","year":"2021","journal-title":"J. Cancer"},{"issue":"10","key":"10.1016\/j.cytogfr.2021.11.002_bib103","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s00262-020-02598-5","article-title":"Activated HIF1alpha of tumor cells promotes chemoresistance development via recruiting GDF15-producing tumor-associated macrophages in gastric cancer","volume":"69","author":"Yu","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"issue":"7","key":"10.1016\/j.cytogfr.2021.11.002_bib104","first-page":"2642","article-title":"MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma","volume":"9","author":"Brown","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.cytogfr.2021.11.002_bib105","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10585-020-10041-3","article-title":"Growth differentiation factor 15 (GDF15) in cancer cell metastasis: from the cells to the patients","volume":"37","author":"Spanopoulou","year":"2020","journal-title":"Clin. Exp. Metastasis"},{"issue":"15","key":"10.1016\/j.cytogfr.2021.11.002_bib106","doi-asserted-by":"crossref","first-page":"24892","DOI":"10.18632\/oncotarget.15279","article-title":"Circulating MIC-1\/GDF15 is a complementary screening biomarker with CEA and correlates with liver metastasis and poor survival in colorectal cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.cytogfr.2021.11.002_bib107","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3233\/CBM-170792","article-title":"Growth\/differentiation factor 15 (GDF-15) as new potential serum marker in patients with metastatic colorectal cancer","volume":"21","author":"Vocka","year":"2018","journal-title":"Cancer Biomark"},{"issue":"2","key":"10.1016\/j.cytogfr.2021.11.002_bib108","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1158\/1055-9965.EPI-11-0786","article-title":"Serum macrophage inhibitory cytokine-1 (MIC-1\/GDF15): a potential screening tool for the prevention of colon cancer?","volume":"21","author":"Brown","year":"2012","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"10","key":"10.1016\/j.cytogfr.2021.11.002_bib109","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/bjc.2011.112","article-title":"Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer","volume":"104","author":"Wallin","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.cytogfr.2021.11.002_bib110","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1053\/j.gastro.2015.05.038","article-title":"Association between plasma levels of macrophage inhibitory cytokine-1 before diagnosis of colorectal cancer and mortality","volume":"149","author":"Mehta","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cytogfr.2021.11.002_bib111","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1080\/21691401.2018.1466146","article-title":"GDF15 promotes epithelial-to-mesenchymal transition in colorectal [corrected]","author":"Zhang","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol. 46(sup2)"},{"issue":"1","key":"10.1016\/j.cytogfr.2021.11.002_bib112","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.18632\/oncotarget.13649","article-title":"GDF15 contributes to radioresistance and cancer stemness of head and neck cancer by regulating cellular reactive oxygen species via a SMAD-associated signaling pathway","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"issue":"48","key":"10.1016\/j.cytogfr.2021.11.002_bib113","doi-asserted-by":"crossref","first-page":"49617","DOI":"10.1074\/jbc.M408796200","article-title":"Identification of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) as a novel downstream target of phosphatidylinositol 3-kinase\/AKT\/GSK-3beta pathway","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.cytogfr.2021.11.002_bib114","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1182\/blood-2016-01-696617","article-title":"GDF-15 inhibits integrin activation and mouse neutrophil recruitment through the ALK-5\/TGF-betaRII heterodimer","volume":"128","author":"Artz","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cytogfr.2021.11.002_bib115","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/01.RES.0000202804.84885.d0","article-title":"GDF15\/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation","volume":"98","author":"Xu","year":"2006","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.cytogfr.2021.11.002_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187349","article-title":"TGF-beta contamination of purified recombinant GDF15","volume":"12","author":"Olsen","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cytogfr.2021.11.002_bib117","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cmet.2018.07.018","article-title":"The MIC-1\/GDF15-GFRAL pathway in energy homeostasis: implications for obesity, cachexia, and other associated diseases","volume":"28","author":"Tsai","year":"2018","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.cytogfr.2021.11.002_bib118","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/nm.4414","article-title":"GDF15 and energy balance: homing in on a mechanism","volume":"23","author":"Cimino","year":"2017","journal-title":"Nat. Med."},{"issue":"7675","key":"10.1016\/j.cytogfr.2021.11.002_bib119","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nature24143","article-title":"Obesity: receptors identified for a weight regulator","volume":"550","author":"Saarma","year":"2017","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.cytogfr.2021.11.002_bib120","first-page":"4262","article-title":"GDF15 promotes osteosarcoma cell migration and invasion by regulating the TGFbeta signaling pathway","volume":"20","author":"Chen","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.11.002_bib121","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13046-018-0744-0","article-title":"GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1\/2 through the receptor ErbB2","volume":"37","author":"Li","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cytogfr.2021.11.002_bib122","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ebiom.2019.04.018","article-title":"Circulating growth\/differentiation factor 15 is associated with human CD56(bright) natural killer cell dysfunction and nosocomial infection in severe systemic inflammation","volume":"43","author":"Kleinertz","year":"2019","journal-title":"EBioMedicine"},{"issue":"3_suppl","key":"10.1016\/j.cytogfr.2021.11.002_bib123","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.3_suppl.116","article-title":"GDF15 expression in metastatic colorectal cancer","volume":"39","author":"Jayachandran","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.cytogfr.2021.11.002_bib124","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1158\/1078-0432.CCR-10-0705","article-title":"GDF-15 contributes to proliferation and immune escape of malignant gliomas","volume":"16","author":"Roth","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.cytogfr.2021.11.002_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078618","article-title":"Growth differentiation factor-15 suppresses maturation and function of dendritic cells and inhibits tumor-specific immune response","volume":"8","author":"Zhou","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2021.11.002_bib126","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.3389\/fimmu.2018.02407","article-title":"GDF15 Regulates Malat-1 Circular RNA and Inactivates NFkappaB Signaling Leading to Immune Tolerogenic DCs for Preventing Alloimmune Rejection in Heart Transplantation","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.11.002_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188359","article-title":"Advances in cancer cachexia: intersection between affected organs, mediators, and pharmacological interventions","volume":"1873","author":"Siddiqui","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"4","key":"10.1016\/j.cytogfr.2021.11.002_bib128","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jcsm.12033","article-title":"Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients","volume":"6","author":"Lerner","year":"2015","journal-title":"J. Cachexia Sarcopenia Muscle"},{"issue":"11","key":"10.1016\/j.cytogfr.2021.11.002_bib129","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/nm1677","article-title":"Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1","volume":"13","author":"Johnen","year":"2007","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.cytogfr.2021.11.002_bib130","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.3892\/ol.2016.5183","article-title":"Growth differentiating factor-15 (GDF-15): A potential biomarker and therapeutic target for cancer-associated weight loss","volume":"12","author":"Lerner","year":"2016","journal-title":"Oncol Lett"},{"issue":"3","key":"10.1016\/j.cytogfr.2021.11.002_bib131","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201948804","article-title":"Muscle-derived GDF15 drives diurnal anorexia and systemic metabolic remodeling during mitochondrial stress","volume":"21","author":"Ost","year":"2020","journal-title":"EMBO Rep"},{"issue":"6","key":"10.1016\/j.cytogfr.2021.11.002_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102554","article-title":"Growth differentiation factor 15 neutralization does not impact anorexia or survival in lipopolysaccharide-induced inflammation","volume":"24","author":"Breen","year":"2021","journal-title":"iScience"},{"issue":"15_suppl","key":"10.1016\/j.cytogfr.2021.11.002_bib133","article-title":"A phase I, first-in-human clinical trial of the GDF-15 neutralizing antibody CTL-002 in subjects with advanced-stage solid tumors (ACRONYM: GDFATHER)","volume":"39","author":"Melero","year":"2021","journal-title":"J. Clin.l Oncol."},{"key":"10.1016\/j.cytogfr.2021.11.002_bib134","article-title":"A 24-month metformin treatment study of children with obesity: Changes in circulating GDF-15 and associations with changes in body weight and visceral fat","author":"Carreras-Badosa","year":"2021","journal-title":"Pediatr. Obes"},{"issue":"4","key":"10.1016\/j.cytogfr.2021.11.002_bib135","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1002\/ehf2.13348","article-title":"Growth differentiation factor-15, treatment with liraglutide, and clinical outcomes among patients with heart failure","volume":"8","author":"Sharma","year":"2021","journal-title":"ESC Heart Fail"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610121000812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610121000812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:00:31Z","timestamp":1761217231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610121000812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":135,"alternative-id":["S1359610121000812"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2021.11.002","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2021.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}